Proton versus photon therapy for esophageal cancer – A trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer

The PROTECT consortium; H. R. Mortensen; P. Populaire; L. Hoffmann; D. S. Moeller; A. Appelt; P. Nafteux; C. T. Muijs; C. Grau; M. A. Hawkins; E. G.C. Troost; G. Defraene; R. Canters; C. S. Clarke; D. C. Weber; E. W. Korevaar; K. Haustermans; M. Nordsmark; Val Gebski; M. P. Achiam; Sheraz R. Markar; Ganesh Radhakrishna; Maaike Berbee; Daniele Scartoni; Ester Orlandi; Jerome Doyen; Vincent Gregoire; Gilles Crehange; Johannes Langendijk; Paula Lorgelly; Hedwig M. Blommenstein; Camilla S. Byskov; Mai L. Ehmsen; Maria Fuglsang Jensen; Gloria Vilches Freixas; Rebecca Bütoft

doi:10.1016/j.radonc.2023.109980

Proton versus photon therapy for esophageal cancer – A trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer

The PROTECT consortium, H. R. Mortensen, P. Populaire, L. Hoffmann, D. S. Moeller, A. Appelt, P. Nafteux, C. T. Muijs, C. Grau, M. A. Hawkins, E. G.C. Troost, G. Defraene, R. Canters, C. S. Clarke, D. C. Weber, E. W. Korevaar, K. Haustermans, M. Nordsmark, Val Gebski, M. P. AchiamSheraz R. Markar, Ganesh Radhakrishna, Maaike Berbee, Daniele Scartoni, Ester Orlandi, Jerome Doyen, Vincent Gregoire, Gilles Crehange, Johannes Langendijk, Paula Lorgelly, Hedwig M. Blommenstein, Camilla S. Byskov, Mai L. Ehmsen, Maria Fuglsang Jensen, Gloria Vilches Freixas, Rebecca Bütoft

Onderzoeksoutput: Editorial › Academic › peer review

5 Citaten (Scopus)

286 Downloads (Pure)

Originele taal-2	English
Artikelnummer	109980
Aantal pagina's	3
Tijdschrift	Radiotherapy and Oncology
Volume	190
DOI's	https://doi.org/10.1016/j.radonc.2023.109980
Status	Published - jan.-2024

Toegang tot document

10.1016/j.radonc.2023.109980

Proton versus photon therapy for esophageal cancerFinal publisher's version, 581 KBLicentie: Taverne

Handle.net

Permanente koppeling

Andere bestanden en links

Link naar publicatie in Scopus

Citeer dit

The PROTECT consortium, Mortensen, H. R., Populaire, P., Hoffmann, L., Moeller, D. S., Appelt, A., Nafteux, P., Muijs, C. T., Grau, C., Hawkins, M. A., Troost, E. G. C., Defraene, G., Canters, R., Clarke, C. S., Weber, D. C., Korevaar, E. W., Haustermans, K., Nordsmark, M., Gebski, V., ... Bütoft, R. (2024). Proton versus photon therapy for esophageal cancer – A trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer. Radiotherapy and Oncology, 190, Artikel 109980. https://doi.org/10.1016/j.radonc.2023.109980

@article{34d3f60c44864b88bbe11470f0978d5d,

title = "Proton versus photon therapy for esophageal cancer – A trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer",

keywords = "Humans, Chemoradiotherapy, Esophageal Neoplasms/surgery, Esophagectomy, Neoadjuvant Therapy, Protons, Clinical Trials, Phase III as Topic, Randomized Controlled Trials as Topic, Multicenter Studies as Topic",

author = "\{The PROTECT consortium\} and Mortensen, \{H. R.\} and P. Populaire and L. Hoffmann and Moeller, \{D. S.\} and A. Appelt and P. Nafteux and Muijs, \{C. T.\} and C. Grau and Hawkins, \{M. A.\} and Troost, \{E. G.C.\} and G. Defraene and R. Canters and Clarke, \{C. S.\} and Weber, \{D. C.\} and Korevaar, \{E. W.\} and K. Haustermans and M. Nordsmark and Val Gebski and Achiam, \{M. P.\} and Markar, \{Sheraz R.\} and Ganesh Radhakrishna and Maaike Berbee and Daniele Scartoni and Ester Orlandi and Jerome Doyen and Vincent Gregoire and Gilles Crehange and Johannes Langendijk and Paula Lorgelly and Blommenstein, \{Hedwig M.\} and Byskov, \{Camilla S.\} and Ehmsen, \{Mai L.\} and Jensen, \{Maria Fuglsang\} and Freixas, \{Gloria Vilches\} and Rebecca B{\"u}toft",

year = "2024",

month = jan,

doi = "10.1016/j.radonc.2023.109980",

language = "English",

volume = "190",

journal = "Radiotherapy and Oncology",

issn = "0167-8140",

publisher = "ELSEVIER IRELAND LTD",

}

The PROTECT consortium, Mortensen, HR, Populaire, P, Hoffmann, L, Moeller, DS, Appelt, A, Nafteux, P, Muijs, CT, Grau, C, Hawkins, MA, Troost, EGC, Defraene, G, Canters, R, Clarke, CS, Weber, DC, Korevaar, EW, Haustermans, K, Nordsmark, M, Gebski, V, Achiam, MP, Markar, SR, Radhakrishna, G, Berbee, M, Scartoni, D, Orlandi, E, Doyen, J, Gregoire, V, Crehange, G, Langendijk, J, Lorgelly, P, Blommenstein, HM, Byskov, CS, Ehmsen, ML, Jensen, MF, Freixas, GV & Bütoft, R 2024, 'Proton versus photon therapy for esophageal cancer – A trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer', Radiotherapy and Oncology, vol. 190, 109980. https://doi.org/10.1016/j.radonc.2023.109980

Proton versus photon therapy for esophageal cancer – A trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer. / The PROTECT consortium; Mortensen, H. R.; Populaire, P. et al.
In: Radiotherapy and Oncology, Vol. 190, 109980, 01.2024.

Onderzoeksoutput: Editorial › Academic › peer review

TY - JOUR

T1 - Proton versus photon therapy for esophageal cancer – A trimodality strategy (PROTECT) NCT050555648

T2 - A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer

AU - The PROTECT consortium

AU - Mortensen, H. R.

AU - Populaire, P.

AU - Hoffmann, L.

AU - Moeller, D. S.

AU - Appelt, A.

AU - Nafteux, P.

AU - Muijs, C. T.

AU - Grau, C.

AU - Hawkins, M. A.

AU - Troost, E. G.C.

AU - Defraene, G.

AU - Canters, R.

AU - Clarke, C. S.

AU - Weber, D. C.

AU - Korevaar, E. W.

AU - Haustermans, K.

AU - Nordsmark, M.

AU - Gebski, Val

AU - Achiam, M. P.

AU - Markar, Sheraz R.

AU - Radhakrishna, Ganesh

AU - Berbee, Maaike

AU - Scartoni, Daniele

AU - Orlandi, Ester

AU - Doyen, Jerome

AU - Gregoire, Vincent

AU - Crehange, Gilles

AU - Langendijk, Johannes

AU - Lorgelly, Paula

AU - Blommenstein, Hedwig M.

AU - Byskov, Camilla S.

AU - Ehmsen, Mai L.

AU - Jensen, Maria Fuglsang

AU - Freixas, Gloria Vilches

AU - Bütoft, Rebecca

PY - 2024/1

Y1 - 2024/1

KW - Humans

KW - Chemoradiotherapy

KW - Esophageal Neoplasms/surgery

KW - Esophagectomy

KW - Neoadjuvant Therapy

KW - Protons

KW - Clinical Trials, Phase III as Topic

KW - Randomized Controlled Trials as Topic

KW - Multicenter Studies as Topic

UR - http://www.scopus.com/inward/record.url?scp=85177493212&partnerID=8YFLogxK

U2 - 10.1016/j.radonc.2023.109980

DO - 10.1016/j.radonc.2023.109980

M3 - Editorial

C2 - 37935284

AN - SCOPUS:85177493212

SN - 0167-8140

VL - 190

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

M1 - 109980

ER -

The PROTECT consortium, Mortensen HR, Populaire P, Hoffmann L, Moeller DS, Appelt A et al. Proton versus photon therapy for esophageal cancer – A trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer. Radiotherapy and Oncology. 2024 jan.;190:109980. doi: 10.1016/j.radonc.2023.109980